Researchers at the Penn State Cancer Research Institute have received $7.5 million from the Susan G. Komen for the Cure Research Program to look at ways to reduce high breast density, a risk factor for breast cancer.
Specifically, the study is examining the effect omega 3 essential fatty acids and of a low dose of antiestrogen medications on high breast density.
The grant, given through Komen's Promise Grants, is one of the largest awarded by Komen for the Cure.
The four-year study includes both clinical trials and animal research, according to Dr. Andrea Manni, one of two researchers heading up the project at the Cancer Institute.
The human part of the study includes five experimental arms involving different dosages of Raloxifene (Evista), an antiestrogen; Lovaza, a prescription dietary supplement of omega-3 fatty acids approved by the Food and Drug Administration; and a combination of the two.
Tuesday July 14, 2009